ENFLONSIA is the first and only RSV preventive option in the European Union for administration to infants without the need for weight-based dosingRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: ...

Merck , known as MSD outside of the United States and Canada, announced today that the European Commission (EC) has approved ENFLONSIAtm (clesrovimab) for the prevention of respiratory syncytial virus ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

REITs have outperformed the S&P 500 over the very long term (25 and 50 years) despite recent underperformance. Dividend income significantly boosts REIT returns, as REITs are required to distribute 90 ...